AtriCure To Acquire SentreHEART For Atrial Fib Tech [Seeking Alpha]
AtriCure, Inc. (ATRC)
Last atricure, inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.atricure.com
Company Research
Source: Seeking Alpha
AtriCure To Acquire SentreHEART For Atrial Fib Tech Summary AtriCure has agreed to acquire SentreHEART for up to $300 million in cash and milestone-based contingent consideration. SentreHEART is developing treatments for atrial fibrillation conditions. With the deal, ATRC will gain entry into the electrophysiology market and the potential of a 1.5 million patient addressable Afib market. Quick Take AtriCure ( announced SentreHEART is developing percutaneous left atrial appendage management solutions. With the deal, ATRC is gaining promising technologies to address the large Afib market and additional relationships in the electrophysiology market that are complementary to its surgical products. Target Company Redwood City, California-based SentreHEART was founded in 2005 to develop the LARIAT Suture Delivery Device for patients with persistent atrial fibrillation. It is currently being evaluated in a FDA-approved randomized controlled trial, known as the ‘aMAZE Trial.’ Management is he
Show less
Read more
Impact Snapshot
Event Time:
ATRC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATRC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATRC alerts
High impacting AtriCure, Inc. news events
Weekly update
A roundup of the hottest topics
ATRC
News
- AtriCure to Participate in the Stifel 2024 Healthcare ConferenceBusiness Wire
- US$42.67 - That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After These Results [Yahoo! Finance]Yahoo! Finance
- AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Canaccord Genuity Group Inc. from $49.00 to $53.00. They now have a "buy" rating on the stock.MarketBeat
- AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Oppenheimer Holdings Inc. from $32.00 to $36.00. They now have an "outperform" rating on the stock.MarketBeat
- AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at JPMorgan Chase & Co. from $30.00 to $40.00. They now have an "overweight" rating on the stock.MarketBeat
ATRC
Earnings
- 10/29/24 - Beat
ATRC
Sec Filings
- 11/14/24 - Form SC
- 11/12/24 - Form SCHEDULE
- 10/30/24 - Form 10-Q
- ATRC's page on the SEC website